tiprankstipranks
Advertisement
Advertisement
Pfizer recommends shareholders reject mini-tender offer by Tutanota
PremiumThe FlyPfizer recommends shareholders reject mini-tender offer by Tutanota
5d ago
Pfizer’s talzenna plus xtandi shows improved survival in prostate cancer
Premium
The Fly
Pfizer’s talzenna plus xtandi shows improved survival in prostate cancer
6d ago
Option traders moderately bearish in Pfizer with shares down 0.75%
Premium
The Fly
Option traders moderately bearish in Pfizer with shares down 0.75%
7d ago
Pfizer announces Phase 2 FOURLIGHT-1 study met primary endpoint
PremiumThe FlyPfizer announces Phase 2 FOURLIGHT-1 study met primary endpoint
8d ago
Pfizer price target raised to $32 from $29 at HSBC
Premium
The Fly
Pfizer price target raised to $32 from $29 at HSBC
8d ago
District court rules federal limits to vaccines not based on science, NYT says
Premium
The Fly
District court rules federal limits to vaccines not based on science, NYT says
9d ago
Pfizer’s New Tafamidis Tablet Study Signals Strategic Lifecycle Move for PFE
PremiumCompany AnnouncementsPfizer’s New Tafamidis Tablet Study Signals Strategic Lifecycle Move for PFE
12d ago
Pfizer Advances Early-Stage Cancer Candidate PF-07994525, Extending Its Oncology Pipeline
Premium
Company Announcements
Pfizer Advances Early-Stage Cancer Candidate PF-07994525, Extending Its Oncology Pipeline
13d ago
Mixed options sentiment in Pfizer with shares down 1.23%
Premium
The Fly
Mixed options sentiment in Pfizer with shares down 1.23%
13d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100